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BACKGROUND: MicroRNA (miRNA), short non-coding RNA, plays role in various physiological process such as aging through epigenetic regulation 
of gene expression. miRNA present intracellular as well as 
extracellular in body fluids. miRNA that present in blood 
circulatory system is often referred as circulatory miRNA 
(c-miRNA).  A number  of  studies  trying  to  identify 
c-miRNAs as biomarker for ageing have been reported, 
but majority did not yield results that corroborate one 
with another. This study reports the identification of a 
differentially expressed c-miRNAs between elderly and 
youth groups of individuals, the first step in tracking specific 
miRNAs that play role in physiologic ageing. 
METHODS: The miRNA expression profiles of 
grandfathers and grandsons from 2 Javanese families 
were compared to select 5 miRNA candidates with widest 
expression difference. The 5 candidates were subjected to 
validation using quantitative polymerase chain reaction 
(qPCR) in 11 elderly men and 9 young men of the same 
ethnicity  to  identify  differentially  expressed  miRNA 
between elder and younger male groups in the represented 
population.  
RESULTS: Amongst 5 selected c-miRNA candidates, 
the hsa-miR-376c-3p was validated to be upregulated 
in the elderly group when compared to the young 
individuals. Bioinformatic analysis using miRTarBase 7.0, 
miRTargetLink Human and GeneCards® Human Gene 
Database suggest the involvement of hsa-miR-376c-3p in 
pathways relevant with cellular ageing.
CONCLUSION: This study showed that hsa-miR-376c-3p 
in the circulating plasma to be significantly upregulated in a 
group of elderly Javanese males compared to their younger 
counterparts. The results of this study warrant further 
study to elucidate the specific role of hsa-miR-376c-3p in 
physiologic ageing mechanism.
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Introduction
Aging is a global problem in both developed and developing 
countries. In 2017, people aged 60 year old and above 
comprise 13% of the global population, and the number 
(percentage) is growing at a rate of about 3% per year. The 
elderly population in Indonesia in 2012 had reached more 
than 7% of the total Indonesian population and it is predicted 
to increase in the higher speed than its counterparts in other 
Asian region and globally after 2050.(1,2)
 The aging process is very complex mechanism, takes 
place throughout one’s lifespan. Although aging can be 
influenced by environmental factors, recent data show that 
genetic and epigenetic factors also play a definitive role in 
aging  regulation  and  lifespan.  One  of  the  epigenetic 
factors is microRNA (miRNA) that influence the modulation 
of gene expression, firstly known in Caenorhabditis elegans.
(3,4) 
 miRNA is a group of single stranded non-coding small 
RNA (17-25 nucleotides), that controls gene expression 
in animals, plants and eukaryotic organisms by mean of 
negative regulation (repressing) of post transcriptional 
gene expression or its target mRNA. The 2-8 nucleotides 
of the 5' miRNA, if partially binds to the target mRNA’s 3' 
untranslated region (UTR) it will inhibit the translation, and 
if binds perfectly it will cause the target messenger RNAs 
(mRNAs) to be deadenylated and degraded, therefore, no 
translation takes place and there is no gene expression 
products. miRNA can also bind to 5' UTR and the coding 
region sequences (CDS) of their target mRNAs.(5,6)  
 The ability of miRNA to regulate multiple target 
genes simultaneously makes the miRNA an important 
regulator in various physiological conditions, especially 
in complex tissues and aging processes involving several 
interconnecting signalling pathways.(7) Several studies 
have also shown that miRNA participates in regulating cell 
cycle stages, cell proliferation, gene expression and stress 
responses. However, the role of miRNA in aging has not 
been comprehensively known.
 Generally miRNA is intracellular, but studies 
have showed that miRNA also can be found in various 
extracellular  fluids,  including  peripheral  blood  plasma 
(8) saliva (9), urine (10), breast milk (11) and culture cell 
supernatant (12). To date, the origin and the functional role 
of circulatory miRNA (c-miRNA) are still incompletely 
known. Of significance, concentration of extracellular 
miRNA in certain body fluids correlates strongly with various 
pathological conditions including cancer, diabetes and tissue 
injury.(13,10) This has led to the development of prognostic 
and diagnostic tests based on the c-miRNA quantification 
with advantages that include minimally invasive sampling, 
high stability, easy and fast quantification of miRNA with 
quantitative polymerase chain reaction (qPCR) devices.
(14,15) The use of miRNA quantification as a biological 
marker is not limited to pathological conditions, but it has 
extended to physiological condition such as ageing process.
 There have been at least 7 studies, including 2 studies 
that used either plasma or serum, trying to identify c-miRNAs 
that differentially expressed in young and old age groups.
(15-21) However, there was no common miRNA that had 
been validated by two or more independent studies. One 
common thing shared amongst the 7 studies was that all the 
7 studies recruited donor subjects of unrelated individuals 
to make the group of young and the group of old. The 
genetic heterogeneity amongst the subjects might underlie 
the failure in identifying certain miRNAs that consistently 
shows the same pattern of differential expression across 
the studies. Hence, this study used a unique and stringent 
approach i.e., profiling the c-mRNAs expression in subjects 
that represent young age and old age groups within same 
families, grandson and grandfather, aiming to identify 
specific c-miRNAs that differentially express in the different 
age groups.
Methods
Sampling of Blood Plasma from Donors
The inclusion criteria of donor sample were: 17-25 years old 
for the younger age group and >65 years old for the older 
age group, male descendant of Java-Indonesia, not smoking, 
not consuming alcohol, generally healthy (not being sick 
and/or under long medications for various diseases such 
as diabetes, heart failure, kidney failure, cancer, abnormal 
liver function) as evidenced by clinical laboratory test, 
and are willing to participate in the study. Additional 
inclusion criteria for the 4 subjects (2 pairs of old and young 
individuals) for miRNA profiling, were that each pair were 
grandfather and grandson from the same family.
 This study was approved by the Ethics Committee 
in the School of Medicine and Health Sciences, 
Universitas Katolik Indonesia Atma Jaya (No. 12/08/
KEP-FKUAJ/2018). Before the sample collection, all the 
research subjects were given some explanation about the 
study before signing the informed consent.
 Ten mL of peripheral blood was taken and collected in 
tubes containing ethylenediaminetetraacetic acid (EDTA) 
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as anti-coagulant. The blood sample was immediately 
centrifuged, then the plasma was stored at -80ºC until 
further analysis.
RNA Extraction
RNA extraction was performed by Exiqon (Vedbaek, 
Denmark). Total RNA from blood plasma was isolated 
using miRCURY™ RNA Isolation Kit-Biofluids (Exiqon), 
following the instruction from the kit manufactory. RNA and 
DNA spike-in were used to ensure the quality of the RNA 
extraction, real time and qPCR steps. Three types of RNA 
spike-ins were used. First was the RNA isolation control: 
UniSp2, UniSp4, UniSp5 (were added to the purification 
to detect any differences in extraction efficiency). Second 
was the cDNA synthesis control: UniSp6 (was added in 
the reverse transcription reaction giving the opportunity 
to evaluate the RT reaction). And lastly was DNA spike-
in (UniSp3) is present on all panels. The DNA spike-in 
consists of a premixed combination of DNA template and 
primers. Deviations in this reaction indicated inhibitions at 
the qPCR level.
 
Profiling of c-miRNA Using the Real-Time qPCR 
Method
The c-miRNAs’ expression profile from two pairs, of 
samples from 2 families were analyzed. miRNA profiling 
using the Real Time qPCR miRNA method and the 
circulatory DNA formation by reverse transcriptase 
using miRCURY LNA™ Universal RT miRNA PCR, 
Polyadenylation and cDNA synthesis kit according to the 
protocol for miRCURY LNA™ Universal RT PCR miRNA 
(Exiqon). Each miRNA was tested in triplicates with real 
time qPCR on the miRNA Ready-to-Use PCR, the Human 
panel I + II ExiLENT SYBR® Green master mix that 
covers 752 miRNA. Amplification was carried out in Light 
Cycler® 480 Real-Time PCR System (Roche, Mannheim, 
Germany) in a plate of 384 wells. The amplification curve 
was analysed using Roche LC software to determine both 
the Cq (with the second method derivative) and the melting 
curve. To monitor haemolysis two miRNAs are used, one 
that is expressed in red blood cells (miRNA-451) and one 
that is relatively stable in serum and plasma and not affected 
by haemolysis (miRNA-23a). Samples with ratios above 
7.0 have an increased risk of being affected by haemolysis.
(22) Samples with lower ratios are generally not affected by 
haemolysis. A ratio of 7.0 has been experimentally validated 
only for humans. 
 For normalization of the data, the average of the assays 
detected in all samples (n=4 samples) was used as this was 
found to be the most stable normalizer. The RNA extraction 
and miRNA profiling were done by Exiqon.
Selection of c-miRNA Candidates and Validation Using 
the Real Time qPCR 
The results of the c- miRNAs’ expression profiling in 
young group and old group, for each family were listed as 
a table in order from the top to bottom as from the largest 
to the smallest fold change of their differential expression. 
The miRNAs from the profiling data were listed in a table 
with the order from the largest difference of absolute 
∆∆Cq at the top, to the smallest of absolute ∆∆cq at the 
bottom.  The first top 5 miRNAs that consistently appeared 
in both miRNA lists from the 2 families were handpicked 
to be miRNA candidates for further validation in samples 
from a group of elderly men and samples from a group 
of younger men using real time qPCR. The validation of 
the selected miRNAs expression was carried out using 
the mSMRT-qPCR miRNA method patented by miRXES. 
RNA, U6 Small Nuclear (RNU6) and hsa-miR-486-5p were 
used as reference genes. The data of the validation output 
were analysed using the GenEx Professional 5.0 program 
(MultiD Analyses AB, Gothenburg, Sweden) and t-test was 
performed for the statistical analysis.
Prediction of miRNA Targets and Enrichment Pathway 
Signaling
The three public available database use for this analysis, 
there are: miRTarBase 7.0 (http://mirtarbase.mbc.nctu.edu.
tw/php/index.php), miRTargetLink Human (https://ccb-
web.cs.uni-saarland.de/mirtargetlink/), and GeneCards® 
Human Gene Database (https://www.genecards.org/) 
to predict target genes and signalling pathways that are 
affected by selected miRNA candidates.
Results
Study Participants and Biological Samples
The recruitment criteria stringency had limited this study 
in recruiting larger number of participants within the 
designated time frame. Two pairs of blood plasma samples, 
each pair were donated by a biologically related grandfather 
and a grandson within a family, were obtained for miRNA 
expression profiling. Additionally, 9 samples from elderly 
men (average age=70.5 year old; SD=5.57) and 11 samples 
from young men (average age=18.5 year old; SD=1.97), 
none are biologically related, were obtained for the miRNA 
expression validation.
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The Profile of Differentially Expressed c-miRNA 
between Young and Old Individuals
The qPCR profiling of miRNA expression in 4 samples 
identified at least 126 miRNAs in each sample, with an 
average of 189 miRNAs per samples. The steady level 
of spike in assays indicated that extraction, reverse 
transcription and qPCR were successful. The steady level 
of the RNA spike-ins, which was comparable to the blank 
purification, also shows that none of the samples contain 
inhibitors (Figure 1A). The haemolysis assessment of the 
samples showed no sign of red blood cell contamination 
(Figure 1B). The profiling results were presented to show the 
differential  expression  between  the  young  individual  and 
an elderly individual. Shown in Table 1 was the list of top 90 
differentially expressed miRNA in family 1 with the lowest 
cut of absolute ∆∆cq at least 1.6, with the order from the 
largest difference of absolute ∆∆cq at the top, to the smallest 
of absolute ∆∆cq at the bottom. The table listed, from top 
to bottom, from the most to the least differentially miRNAs 
expressed between the younger and elder individual in 
family 1. Forty-three miRNAs were upregulated while 
47 miRNA are downregulated in the grandfather when 
compared to those of the grandson.
 Data from both families showed high similarity 
by sharing 18 % of total miRNAs in the top 90. Figure 2 
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Figure 1. Spike-in raw Cq-values and the difference of Cq-values. A: The raw Cq-values obtained from the control assays. B: The 
difference of Cq-values between hsa-miR-23a-3p and hsa-miR-451a (∆Cq 23a-451) ratio from the samples. The hemolysis assessment of 
the samples in this study showed no sign of red blood cell contamination. Pls-1A: elder man from family 1; Pls-1B: young man from family 
1; Pls 2A: elder man from family 2; Pls-2B: younger man rom family 2.
showed the heatmap presentation of the top 50 from the list 
to show the contrasting differential expression between the 
young and old individuals in family 1. 
The Selected c-miRNA Candidates and The Validated 
c-miRNA That Differentially Expressed in Young and 
Old Individuals
Based on the profiling data from 2 families, 5 miRNAs, 
namely hsa-miR26a -5p, hsa-miR-214-3p, hsa-miR-376c-
3p, hsa-miR345-5p, and hsa-miR-574-3p, were selected for 
further validation using qPCR in 20 samples, 9 of elderly 
and 11 of young men. Out of 5 candidates, hsa-miR-376c-3p 
was validated to be upregulated in the elderly group (average 
of ∆cq=1.83; SD=2.02) when compared to the young men 
group (average ∆cq=0.012 ; SD=1.09). The expression of 
hsa-miR-376c-3p in older me group is 3.5 times more than 
that their younger counterpart with significant value of 0.01 
(Figure 3). 
Prediction of miRNA Targets and Enrichment Pathway 
Signalling
Analysis using miRTarBase 7.0 showed 7 genes as direct 
targets of miR-376c-3p evidently confirmed by either 
reporter gene assay, qPCR, or Western Blot, or their 
combination (Table 2).  The 7 genes were Activin A 
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Figure 2. Heatmap presentation of the top 
50 c-miRNAs, contrasting comparison 
between c-miRNAs expression grandfather 
(A) and grandson (B) and in family 1. The 
strength of expression can be seen from the 
intensity of the colour, the weak expression is 
shown in dark red and increases to pink, bluish 
white, light blue and the strongest expression 
is shown in dark blue. Twenty-seven (54%) 
miRNAs are upregulated and 23 (46%) 
miRNAs are downregulated in the grandfather 
when compares to those of the grandson.
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Figure 3. Result of the miR376c-3p validation across 20 
individuals shown in expression profile. 
Receptor Type 1C (ACVR1C), Growth Factor Receptor 
Bound Protein 2 (GRB2), Insulin Like Growth Factor 1 
Receptor (IGF1R), Transforming Beta Receptor Growth 
Factor 1 (TGFBR1), Transforming Growth Factor Alpha 
(TGFA), BMI1 Proto-Oncogene (BMI1), and Run Related 
Transcription Factor 2 (RUNX2). Signalling pathways that 
were affected include insulin, mTOR, apoptosis, autophagy, 
and cellular senescence.
Discussion
C-miRNA  has  initially  been  studied  for  its  biological 
property as a marker of the presence and/or progressive 
of diseases such as cancer, Alzheimer Disease, 
neurodegenerative diseases, diabetic and other ageing-
associated diseases. Recently the research on miRNA in 
ageing has developed into deeper area including to explore 
the usefulness of miRNA as biomarker that can shed light 
on the biological process of ageing, to predict whether 
someone will likely lead a healthy long life or, in opposite, 
soon will develop age related diseases leading to the death 
(23), and even to predict one’s chronological age, similar to 
the property owned by DNA methylation (24). 
 So far, there were 10 studies on c-miRNA in relevance 
with ageing that used different specimens such as whole 
blood, peripheral blood mononuclear cells (PBMC), plasma 
or serum.(14-21,23,24) Of note, 7 out of the 10 studies 
(15-21), all aimed to identify differentially expressed 
miRNA in different age groups, yielded no corroborating 
results, or in other words there was no overlapping result 
amongst the 7 studies. Some of the studies even presented 
confusing results, for instance one study reported miR-376 
to be upregulated in older people (25) while  another  study 
reported miR376 to be downregulated in older people (23). 
Only the latest 3 studies (14,23,24), showed 3 miRNAs 
that appeared in more than one studies, namely miR-24, 
miR340-3p and miR-130b-5p. Amongst those 3 miRNAs 
only miR340 that appeared in 4 studies (14,16,23,24). Such 
random results may be partly due to the use of blood, which 
in fact contains various elements.(24)
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1B 1A 1A-1B Fold Change Absolute
Average ∆cq Average ∆cq ∆∆cq 2∆∆cq ∆∆cq
1 hsa-miR-30e-3p -3.035 -7.305 -4.27 0.052 4.27
2 hsa-miR-301a-3p -6.181 -2.763 3.418 10.69 3.418
3 hsa-miR-7-1-3p -1.917 -5.249 -3.332 0.099 3.332
4 hsa-miR-339-5p -4.623 -2.318 2.306 4.944 2.306
5 hsa-miR-328-3p -3.406 -1.230 2.176 4.52 2.176
6 hsa-miR-205-5p -1.430 -3.605 -2.175 0.221 2.175
7 hsa-miR-17-5P -3.851 -5.993 -2.143 0.226 2.143
8 hsa-miR-106a-5p 1.213 3.318 2.104 4.3 2.104
9 hsa-miR-203a -3.642 -5.695 -2.053 0.241 2.053
10 hsa-miR-181a-3p -5.969 -3.94 2.03 4.083 2.03
11 hsa-miR-193a-5p -3.756 -5.754 -1.998 0.25 1.998
12 hsa-miR-424-5p -0.165 -2.122 -1.957 0.258 1.957
13 hsa-miR-200a-3p -3.181 -5.124 -1.943 0.26 1.946
14 hsa-miR-663b -7.098 -5.171 1.928 3.804 1.928
15 hsa-miR-195-5p -3.304 -5.159 -1855 0.276 1.855
16 hsa-miR-598-3p -4.629 -2.786 1.843 3.587 1.843
17 hsa-miR-550a-3p -4.811 -6.613 -1.802 0.287 1.802
18 hsa-miR-502-5p -6.422 -4.658 1.764 3.396 1.764
19 hsa-miR-331-3p -5.166 -2.412 1.754 3.372 1.754
20 hsa-let-7b-3p -3.220 -4.943 -1.724 0.303 1.724
21 hsa-miR-1249 -6.445 -4.867 1.578 2.986 1.578
22 hsa-miR-197-3p -2.631 -1.071 1.56 2.948 1.56
23 hsa-miR-26b-5p -1.972 -3.531 -1.558 0.34 1.558
24 hsa-miR-223-5p -2.351 -3.887 -1.536 0.345 1.536
25 hsa-miR-376c-3p -3.791 -2.29 1.501 2.83 1.501
26 hsa-miR-27a-5p -6.376 -4.88 1.497 2.822 1.497
27 hsa-miR-146b-5p -5.369 -3.882 1.486 2.802 1.486
28 hsa-miR-193b-3p -2.756 -1.332 1.424 2.684 1.424
29 hsa-miR-624-5p -7.268 -5.852 1.416 2.669 1.416
30 hsa-miR-26b-3p -5.460 -4.057 1.403 2.645 1.403
31 hsa-miR-144-5p -1.773 -0.435 1.338 2.529 1.338
32 hsa-miR-152-p -2.244 -0.915 1.329 2.512 1.329
33 hsa-miR-26a-5p -0.293 1.024 1.317 2.491 1.317
34 hsa-miR-15a-5p 4.807 3.535 -1.272 0.414 1.272
35 hsa-miR-547-3p -2.018 -0.763 1.255 2.387 1.255
36 hsa-miR-130b-5p -4.226 -5.466 -1.24 0.423 1.24
37 hsa-miR-940 -5.561 -6.772 -1.211 0.432 1.211
38 hsa-miR-511-5p -3.845 -5.017 -1.173 0.444 1.173
39 hsa-miR-499a-5p -3.627 -4.778 -1.151 0.45 1.151
40 hsa-miR-148b-3p 0.368 -0.767 -1.135 0.455 1.135
41 ha-miR-141-3p -2.601 -3.727 -1.126 0.458 1.126
42 hsa-miR-151a-5p -0.646 0.477 1.123 2.179 1.123
43 hsa-miR-365a-3p -1.519 -2.62 -1.101 0.466 1.101
44 hsa-miR-493-5p -5.272 -4.209 1.063 2.089 1.063
45 hsa-left-7f-5p -2.649 -1.633 1.016 2.022 1.016
miRNA NameNo.
Table 1. Top 90 differentially expressed miRNA between grandfather (A) and grandson (B), data of profiling in Family 1.
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1B 1A 1A-1B Fold Change Absolute
Average ∆cq Average ∆cq ∆∆cq 2∆∆cq ∆∆cq
46 hsa-miR-99a-5p 0.074 -0.924 -0.998 0.501 0.998
47 hsa-miR-95-3p -4.778 -3.789 0.989 1.985 0.989
48 hsa-miR-214-3p -4.667 -3.704 0.963 1.949 0.963
49 hsa-miR-21-5p 5.607 4.651 -0.956 0.515 0.956
50 hsa-miR-30c-5p -1.068 -0.12 0.948 1.929 0.948
51 hsa-miR-20b-5p -5.205 -6.153 -0.948 0.518 0.948
52 hsa-miR-223-3p 5.068 6.014 0.945 1.926 0.945
53 hsa-miR-32-5p 0.68 -0.247 -0.928 0.526 0.928
54 hsa-miR-30a-5p -2.333 -3.247 -0.915 0.531 0.915
55 hsa-miR-7g-5p 1.128 2.043 0.914 1.885 0.914
56 hsa-miR-132-3p -2.364 -3.266 -0.902 0.535 0.902
57 hsa-miR-200c-3p -3.152 4.051 -0.899 0.536 0.899
58 hsa-miR-199a-5p -1.728 -0.843 0.885 1.847 0.885
59 hsa-miR-874-3p -2.289 -3.164 -0.875 0.545 0.875
60 hsa-miR-103a-3p 1.397 2.26 0.863 1.819 0.863
61 hsa-miR-148a-3p -0.398 -1.258 -0.86 0.551 0.86
62 hsa-miR-1260a -1.78 -2.626 -0.846 0.556 0.846
63 hsa-miR-125a-5p -0.348 -1.193 -845 0.557 0.845
64 hsa-miR-10a-5p -6.379 -7.219 -0.84 0.559 0.84
65 hsa-miR-660-5p 1.182 0.359 -0.824 0.565 0.824
66 hsa-miR-139-5p -1.423 -2.246 -0.823 0.565 0.823
67 hsa-miR-29c-3p 1.717 0.898 -0.819 0.567 0.819
68 hsa-miR-133a-3p -2.2 -3.008 -0.809 0.571 0.809
69 hsa-miR-221-3p 0.432 1.235 0.803 1.744 0.803
70 hsa-miR-18b-5p -1.381 -0.587 0.794 1.734 0.794
71 hsa-miR-423-5p 0.505 -0.286 -0.79 0.578 0.79
72 hsa-miR-20a-5p 3.328 4.111 0.783 1.72 0.783
73 hsa-miR-766-3p -3.784 -3.002 0.782 1.719 0.782
74 hsa-miR-362-5p -7079 -6.302 0.777 1.714 0.777
75 hsa-miR-33b-5p -5.835 -5.076 0.759 1.693 0.759
76 hsa-miR-128-3p -3.818 -3.066 0.752 1.684 0.752
77 hsa-miR-185-5p 3.331 4.069 0.738 1.668 0.738
78 hsa-miR-194-5p -0.563 -1.3 -0.736 0.6 0.736
79 hsa-miR-215-5p -0.919 -0.183 0.735 1.665 0.735
80 hsa-miR-33a-5p -4.623 -5.344 -0.721 0.607 0.721
81 hsa-miR-199a-3p -0.167 0.553 0.72 1.647 0.72
82 hsa-miR-210-3p -0.527 -1.242 -0.715 0.609 0.715
83 hsa-miR-7c-5p -2.119 -2.829 -0.71 0.611 0.71
84 hsa-miR-362-3p -1.777 -2.486 -0.709 0.612 0.709
85 hsa-miR-345-5p -0.582 0.102 0.684 1.607 0.684
86 hsa-miR-150-5p 1.785 2.463 0.678 1.6 0.678
87 hsa-miR-144-3p 4.095 3.422 -0.673 0.627 0.673
88 hsa-miR-425-3p -2.642 -3.312 -0.67 0.628 0.67
89 hsa-miR-122-5p 1.733 1.081 -0.653 0.636 0.653
90 hsa-miR-374b-5p -2.499 -1.849 0.65 1.569 0.65
miRNA NameNo.
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 Other possible factors contributing to the non-
corroborating results are (i) non stringent criteria for subject 
recruitment, e.g., inclusion subjects with medical condition 
or under medication, (ii) difference in age grouping or cut 
off of young age - old age, (iii) different technology platform 
used to measure miRNA expression, (iv) different way of 
measurement, e.g. a study that pooled RNA from multiple 
subjects to be run sequencing as one sample.(14)
 Because of all the above, aiming to obtain more 
reliable data, this reported study set unique criteria for the 
subjects whom the specimens would be collected from. This 
includes (i) subjects of being biological grandfather and 
grandson from whom plasma specimens were collected for 
miRNA expression profiling. The comparison analysis was 
performed separately for each family. All the above to avoid 
any bias caused by interfamily genetic heterogeneity, (ii) 
Very stringent inclusion and exclusion criteria for subjects 
whom plasma specimens were collected for validation so 
that certain pathological conditions, as well as external 
condition such as cytotoxic medication, long medication, 
and smoking, would not add noise to the data. The rather 
small number of the biological samples is indeed a limitation 
of this study.  
 However, the study was able to show convincing 
results both in miRNA expression profiling, and reaffirmed 
in the validation. Hence, this study demonstrates a rational 
approach, particularly by the efforts to minimize factors 
other than the age that may compromise the nature of the 
miRNA expression.
 The miRNA expression profiling in this study showed 
interesting results. Among the top 90 list we identified a 
group of miRNAs where the regulation are in accordance 
with previous studies, and a group of miRNAs where the 
regulation are in contradictory with the previous studies. In 
the first group, we identified the downregulation of miR-21-
5p that previously was reported as potential biomarker for 
trajectory ageing (23), as well as upregulation of miR30c-
5p, miR-103a-3p, and downregulation of miR-17-5p that 
previously reported as part of important miRNAs that 
together could reverse ageing markers in mice (26). In the 
second group, we identified the downregulation of miR-
181a-5p, miR-106a-5p, and upregulation of miR30a-5p 
that have previously been reported as the opposite in some 
previous studies.(15,21,27) 
 The qPCR validation on the samples from unrelated 
individuals clearly validated hsa-miR-376c-3p to be 
upregulated amongst elderly Javanese male compared to 
their younger counterparts. As far as we are aware of, this 
is the first time for hsa-miR-376c-3p being identified to be 
c-miRNA upregulated in the elder person. Previously there 
was one study showed the upregulation of hsa-miR-376 
in older persons when compared to younger persons (25), 
however it was not specifically identified whether the 
miRNA was produced from which genetic locus and whether 
it was from 5’ or 3’ arm.  Another study, identified hsa-miR-
376c-3p, amongst other miRNAs, to be downregulated in 
persons who likely to live a longer healthy life compared to 
those who lived shorter life.(23) However, we can’t directly 
compare our study with that study as it compared the serum 
hsa-miR-376c-3p expression of persons at their age of 50 
year old, 55 year old, and 60 year old.(22) In our study the 
elderly group participants were males of 65 year old and 
older, while the younger group were males of age 17 to 25 
year old. 
 The miR-376c-3p has been studied quite widely in 
various cancer (28-31), there have not been much study 
on the role of hsa-miR-376c-3p in physiologic ageing. 
Bioinformatic analysis on the hsa-miR-376c-3p and its 
strong targets, including Cyclin D1 (CCND1) that just 
recently demonstrated (29), showed affected signalling 
pathways such as insulin, mTOR, apoptosis, autophagy, and 
cellular senescence. These suggest that hsa-miR-376c-3p 
may play role in cellular ageing.
Conclusion
This study showed that, for the first time, the upregulation 
of hsa-miR-376c-3p in the circulating plasma of the 
elderly Javanese males when compared to their younger 
counterparts. This finding, together with the accumulating 
knowledge on its direct target genes, warrant further study 
to elucidate the specific roles of hsa-miR-376c-3p in 
physiological ageing mechanism. 
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